Clinical Trial Update: DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution

View source ↗

Summary

A clinical trial registry update for the DOLCE study evaluating the impact of Optellum's AI lung cancer prediction solution. The trial, sponsored by Nottingham …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Nodules

Snippet

Sponsor: Nottingham University Hospitals NHS Trust | Conditions: AI (Artificial Intelligence), Pulmonary Nodule, Solitary | Status: RECRUITING